Texas HIV Medication Program
Apply | Questions? | Contact Us
The Texas HIV Medication Program (THMP) provides medications for the treatment of HIV and its related complications for low-income Texans. To qualify for medications, potential clients who meet eligibility criteria complete an application for assistance. Once approved, a client receives medications at an assigned pharmacy in their community.
To learn more about the THMP and find out if you are eligible, see the Frequently Asked Questions. You can apply for the program by downloading and completing the client application. Be sure and review the specific “application instructions” when completing the application. The application and its instructions are located on the THMP document page. If you have more questions or need assistance completing your application, call the THMP toll-free at 800-255-1090.
The THMP is the official AIDS Drug Assistance Program (ADAP) for the State of Texas. The THMP has been in existence since 1987 and provides medications approved by the Food and Drug Administration (FDA) for the treatment of illnesses caused by the human immunodeficiency virus (HIV) and other opportunistic infections in HIV-infected individuals as prescribed by their doctor. THMP also operates the Texas HIV State Pharmaceutical Assistance Program (SPAP), which helps HIV-positive individuals that do not qualify for the full Low-Income Subsidy (extra help) with their out-of-pocket costs associated with Medicare Part D prescription drug plans, including co-payments, deductibles, coinsurance, and during the coverage gap (the "donut hole").
Formulary Addition
A medication has been added to the THMP Formulary as a 90-day option:
- Delstrigo-90 Day (doravirine/lamivudine/tenofovir), 100/300/300 mg tablets, #30 per bottle (to be ordered for 3 bottles)
The Medical Certification Form and THMP Formulary have been updated. Both can be found on the THMP documents page.
Texas HIV Medication Program Notifications
DSHS has three important notifications for clients participating in THMP. Please review the information provided and contact us at 1-800-255-1090 or hivstd@dshs.texas.gov if you have any questions.
First, beginning April 1, 2023, THMP began using a new method to determine eligibility for the program. The new method will create a more equitable and transparent eligibility process.
Currently, THMP determines financial eligibility by subtracting personal HIV drug costs from a person’s income. Beginning April 1, 2023, THMP determined financial eligibility by subtracting $12,240 from a person’s income. This standard deduction is the average drug cost per THMP client. The standard deduction will be $12,240 for this first year, from April 1, 2023, to March 31, 2024. Each year, THMP will adopt a new standard deduction amount of the average client drug cost.
If you are a new client, THMP began using this new eligibility effective April 1, 2023. If you are an existing client, THMP uses the standard deduction to determine your eligibility during your annual recertification period. If your recertification period was after April 1, 2023, your eligibility remained the same until your next annual recertification. At that time, THMP will use the new method to determine your eligibility.
You should contact your case worker to understand how this change will affect you. You can find the notification at Texas DSHS HIV/STD Program - Texas HIV Medication Program.
Second, THMP reinstated the ten medications below, effective April 1, 2023.
These medications are available to new and existing enrollees. Existing participants will receive a letter by March 1, 2023, informing them that these medications are now available.
Name Brand (Generic) | Indications |
---|---|
Amlodipine | Hypertension |
Atorvastatin | Statin |
Hydrochlorothiazide (HCTZ) | Hypertension |
Lisinopril | Hypertension |
Metformin HCL | Diabetes |
Metoprolol Tartrate | Hypertension |
Trazadone | Psychiatric |
Duloxetine | Psychiatric |
Gabapentin | Psychiatric |
Sertraline | Psychiatric |
Please share this information with those you know this change may impact.
Third, if you are a current Take Charge Texas (TCT) user and would like to provide feedback on future enhancements, contact THMP at hivstd@dshs.texas.gov and include “TCT Feedback” in the subject line.
THMP will invite those who email to see demonstrations of future system enhancements and give you the opportunity to provide feedback upon viewing the demonstration.
New Dosages of Three Medications Used To Treat HIV in Infants and Children Have Been Approved for Addition to the THMP Formulary
New dosages of three medications used to treat HIV in infants and children have been approved by the Department of State Health Services (DSHS) Commissioner of Health in addition to the Texas HIV Medication Program (THMP) AIDS Drug Assistance Program (ADAP) Formulary:
- Tivicay PD (dolutegravir) 25 mg
- Isentress (raltegravir) 25 mg
- low-dose Biktarvy (bictegravir 30 mg/emtricitabine 120 mg/tenofovir alafenamide 15 mg)
DSHS was able to estimate the fiscal impact of this change with reasonable certainty based on current data related to pediatric client loads and medication usage. The estimated fiscal impact of this change is minimal, with the possibility of a resulting positive fiscal impact when compared with maintaining only the current pediatric options. Consequently, DSHS is able to support these additions within existing monies and has approved adding these pediatric medications to the formulary.
The THMP formulary has been updated.
Please submit a new THMP Medical Certification Form (MCF) for any infants and children in need of these new medication doses.
Thanks to the Medication Advisory Committee for recommending these changes.
Formulary Addition
A medication has been added to the THMP Formulary:
- Rukobia (fostemsavir tromethamine), 600 mg tablets, #60 per bottle
The Medical Certification Form and THMP Formulary have been updated. Both can be found on the THMP documents page.
Program applications, guidelines, and formulary listings are available on the THMP document page.
THMP Email List
Sign up to one or more email lists below today to receive timely and relevant news from THMP:
Subscribe to THMP News - Less frequent updates with news about significant events for the THMP program.
Subscribe to THMP Participating Pharmacies - Updates of interest to THMP participating pharmacies.
Subscribe to THMP Eligibility - Information for ADAP Enrollment Workers and others who assist clients in THMP application submission and their supervisors.
Book traversal links for Texas HIV Medication Program
-
-
-
- TB Epidemiology Reports and Fact Sheets
-
- Epi Profile - Data Tables
- Epi Profile Section 3 - Affected Populations
- Epi Profile Section 6 - Mortality
- Epi Profile Section 7 - At-Risk Populations
- Epi Profile Section 8 - Drug Resistant Tuberculosis
- Epi Profile Section 9 - Public Health Follow-Up Outcomes
- Epi Profile Section 2 - Geographic Distribution of TB in Texas
- Epi Profile Section 4 - Case Diagnosis
- Epi Profile Section 5 - Recent Transmission
- Epi Profile Section 10 - Reporting Requirements
- Epi Profile Section 11 - References
- Epi Profile Section 1 - An Overview of Tuberculosis in Texas
- TB News and Announcements
- How to Report Tuberculosis
- TB Forms Resources
- Frequently Asked Questions About TB
-
- Contact Us
-
- Pubic Lice
- Scabies
- Bacterial Vaginosis (BV)
- Hepatitis D
- Hepatitis E
- Yeast Infection/Thrush (Candidiasis)
- Trichomoniasis
-
-
- Congenital Syphilis - Data and Surveillance
- Congenital Syphilis - Exploring an Epidemic Podcast
- Congenital Syphilis - Program Resources
- Congenital Syphilis - Provider Resources
- Congenital Syphilis - A Call to Action: Rising Rates of Congenital Syphilis in Texas
- Penicillin G Benzathine (Bicillin L-A) Shortage
-
- Pelvic Inflammatory Disease (PID)
- Human Papillomavirus (HPV)
- Chlamydia
- Herpes Simplex Virus (HSV)
- Gonorrhea
-
-
- HIV/STD Service Providers - Palestine - Plano
- HIV/STD Service Providers - Galveston
- HIV/STD Service Providers - Abilene - Amarillo - Arlington - Austin
- HIV/STD Service Providers - Richmond - Robstown
- HIV/STD Service Providers - Hallettsville - Harlingen - Hillsboro - Houston
- HIV/STD Service Providers - Beaumont - Belton - Bryan
- HIV/STD Service Providers - San Angelo - San Antonio - San Marcos - Sherman
- HIV/STD Service Providers - Killeen - Kingsville
- HIV/STD Service Providers - Cameron - Cleveland - Corpus Christi - Cotulla
- HIV/STD Service Providers -Temple - Texarkana - Texas City - Tyler
- HIV/STD Service Providers - Laredo - Longview - Lubbock - Lufkin
- HIV/STD Service Providers - Dallas - Denton
- HIV/STD Service Providers - Uvalde - Victoria
- HIV/STD Service Providers - McAllen - McKinney - Midland
- HIV/STD Service Providers - Eagle Pass - El Paso
- HIV/STD Service Providers - Waco - Wichita Falls
- HIV/STD Service Providers - Nacogdoches - Odessa
- HIV/STD Service Providers - Farmers Branch - Fort Worth
- HIV Administrative Agencies
- HIV and STD Testing in Texas
-
- HIV and Viral Hepatitis Prevention and Treatment Resources in Texas
-
- Border Report Section 3 - Population and Demographics of the Texas-Mexico Border Region
- Border Report Section 4 - HIV Diagnoses and People Living with HIV
- Border Report Section 2 - HIV, STDs, and TB in the Texas-Mexico Border Region
- Border Report Section 1 - Executive Summary
- Border Report Section 5 - Sexually Transmitted Diseases
- Border Report Section 6 - Tuberculosis
- Border Report - Table Appendix
-
- Epi Profile Section 3 - Texans with New HIV Diagnoses
- Epi Profile Section 7 - Comorbidities in Texans Living with HIV
- Epi Profile - Table Appendix
- Epi Profile - Data Sources and Notes
- Epi Profile Section 1 - Executive Summary
- Epi Profile Section 11 - HIV Treatment Cascade
- Epi Profile Section 2 - Texans Living with HIV in 2018
- Epi Profile Section 4 - New Diagnoses in MSM
- Epi Profile Section 5 - Texans with Newly Acquired HIV
- Epi Profile Section 6 - Deaths in Texans Living with HIV
- Epi Profile Section 8 - HIV Testing in Programs Funded by the Department of State Health Services
- Epi Profile Section 9 - Sex and Substance Use in PLWH
- Epi Profile Section 10 - Sex and Substance Use in People at Increased Risk for HIV in Dallas, Texas
-
Contractor Resources - HIV Medical and Psychosocial Support Services Open submenu links Close submenu links
- HIV Services Program Reports
- Technical Assistance
-
- Outpatient/Ambulatory Health Services
- Universal Standards
- Home and Community-Based Health Services
- Referral for Health Care and Support Services
- Non-Medical Case Management
- Home Health Care
- Rehabilitation Services
- Early Intervention Services
- Oral Health Services
- Hospice Services
- Respite Care
- Food Bank-Home Delivered Meals
- Other Professional Services
- Housing Services
- Health Education/Risk Reduction (HE/RR)
- Outreach Services
- Linguistic Services
- Telemedicine Guide Resources
- Health Education-Risk Reduction (HE/RR) - Minority AIDS Initiative
- Outreach Services - Minority AIDS Initiative (MAI)
- Medical Nutrition Therapy (MNT)
- Health Insurance Premium and Cost Sharing Assistance
- Psychosocial Support Services
- Medical Transportation Services
- Emergency Financial Assistance (EFA)
- Child Care
- Local AIDS Pharmaceutical Assistance (LPAP)
- Medical Case Management (including Treatment Adherence Services)
- Mental Health Services
- Substance Abuse Outpatient Care
- Substance Abuse Services (Residential)
- Housing Opportunities for Persons With AIDS (HOPWA)
-
-
- Texas HIV Surveillance Procedure Manual
- HIV/AIDS Data Changes 2010
- Medical Monitoring Project (MMP)
-
-
- THISIS FAQ Labs
- THISIS FAQ System Access
- THISIS FAQ Clinical
- THISIS FAQ Event
- THISIS FAQ Follow-Up
- THISIS FAQ Helpful Tips
- THISIS FAQ Transition to THISIS
- THISIS FAQ Workflows
- THISIS FAQ HIV Surveillance
- THISIS FAQ Notes
- THISIS FAQ Partner-Clusters
- THISIS FAQ Public Health Follow-Up
- THISIS FAQ Reporting-Morbidity
- THISIS FAQ Reports
- THISIS FAQ Risk Factors
- THISIS FAQ Syphilis
- THISIS FAQ Case Assignment Field Record
- THISIS FAQ Co-Infection Management
- THISIS FAQ Congenital Syphilis
- THISIS FAQ Facilities
- THISIS FAQ General
- THISIS FAQ Assigning and Tracking Cases-Field Records
- THISIS Training Videos
- THISIS Resources and Forms
- THISIS Glossary
- THISIS Help Desk
- THISIS Training Manuals
- THISIS Tip Sheets
- THISIS Workflows
- THISIS System Status
-
- DSHS TB/HIV/STD Security and Database Account Management
-
-
- Ongoing HIV-STD Training and Educational Resources
- Care Services Training
- Core Training
-
- Training - HIV Navigation in Texas
- Training - Social Determinants of Health
- Training - Trauma Informed Care
- Training - Health Equity
- Training - Foundations of HIV Testing and Navigation
- Training - Gender and Sexual Diversity
- Training - Healthy Options
- Training - Advanced Motivational Interviewing
- Training - Unconscious Bias
- HIV/STD Planning
-
-
-
- 700.006 Multi-Month and Special Circumstance Medication Supply and Coverage
- 700.007 Texas Insurance Assistance Program
- PMCY01 Prescription Medication Shortages
-
591.000 Limitations on Ryan White and State Services Funds for Incarcerated Persons in Community Facilities Open submenu links Close submenu links
- 700.003 HIV/STD Medication Pharmacy Eligibility Criteria
- 700.004 HIV Medications Ordering Process for Pharmacies
- LIDS 2021.001 Program Income
- 2013.01 Ryan White Part B/State Funded Services in Special Care Facilities
- 2012.01 Overall Responsible Party for TB/HIV/STD Surveillance Data
- 2011.04 Breach of Confidentiality Response
- 2011.01 Confidential Information Security
- 035.001 Model Education Program for use by Employers to Educate Employees About the HIV Disease and its Progressive Stages
- 090.001 Roles and Responsibilities of the Section Regarding Contractors
- 090.020 Model Policies for Handling, Caring and Treating Persons Infected with a Sexually Transmitted Disease (Including HIV/AIDS) while in the Custody, Supervision or Care of Correctional, Law Enforcement, and/or Emergency Services Entities
- 090.002 HIV Client Services Funding Allocation Formula
- 090.010 Contract Monitoring
- 090.021 HIV/AIDS Model Workplace Guidelines for Businesses, State Agencies, and State Contractors
- 120.100 HIV Testing of Pregnant Women
- 302.001 Release of Tuberculosis (TB), Human Immunodeficiency Virus (HIV), Sexually Transmitted Disease (STD) and Viral Hepatitis Data
- 500.002 Environmental Tobacco Smoke Contractor Assurance
- 500.003 Contractor Use of Equipment and Supplies Contractor Assurance
- 520.001 Consultant Services and Consulting Fees Paid by a Contractor Through Direct Costs
- 520.002 Staff Education, Association Memberships, Training Fees and Insurance Payments Using Contract Funds
- 525.001 Enforcement of Year End Requirements for DSHS Contracts
- 530.002 Section Expectations and Provider Rights Regarding the Delivery of Client Service
- 530.003 How to Deal With Clients Who Threaten to Harm Themselves or Others
- 540.001 Sanctions Imposed Upon a Contractor for Non-Compliance with Contracts Involving State/Federal Funds
- 540.002 Sanctioning an HIV/STD Contractor for Subcontractor Noncompliance
- 590.001 DSHS Funds as Payment of Last Resort
- 110.002 HIV and STD Prevention Activities in State Prisons and Jails, State Juvenile Justice Facilities, Municipal and County Jails, Federal Prisons, and Private Prisons
- 130.001 Condom Distribution Non-Contracting Prevention Sites
- 220.001 Eligibility to Receive HIV Services
- 231.001 ARIES Security
- 231.000 TakeChargeTexas (TCT) Users
- 231.002 TakeChargeTexas (TCT) Administrative Agency Data Managers’ Core Competencies
- 231.003 TCT Data Improvement Plan
- 241.001 Administrative Agency Roles and Responsibilities
- 241.003 Subcontracting HIV Health and Support Services
- 241.004 Administrative Agency Requirements for Community Input
- 241.005 Conflict of Interest in Administrative Agencies
- 241.006 Reallocation of HIV Client Services Funds
- 260.001 Care for Children Affected by HIV/AIDS Using State Services Funds
- 260.002 Health Insurance Assistance
- 270.001 Calculation of Estimated Expenditures on Covered Clinical Services
- 280.001 Sub-Contracting HIV Core and Support Services by an Administrative Agency
- 420.002 Provider Selection Criteria and Requirements for the Texas Infertility Prevention Project
- 700.001 Texas HIV Medication Program Requests to Change State HIV Medication Formulary
- 700.002 Rights of the Texas HIV Medication Program to Limit the Number of Clients Assigned to a Pharmacy
- 700.005 Medicare Part D
- 2020.02 DSHS Central Pharmacy to Dispense Medications to THMP Participants
- 2016.02 TB/HIV/STD Section Section-Wide Purchasing
- 2015.02 TB/HIV/STD Section Meeting Planning
- 2012.03 Alternative Worksite Procedure Due to Power Outage, HVAC System Failure and Other Temporary Environmental Factors
- 2009.01 TB/HIV/STD Section Procedure for the Review of New Grant Applications, Grant Renewal Applications, Grant Progress Reports and Technical Review Responses
- 2015.03 Creating E-Learning Products for the TB/HIV/STD Section
- 2016.03 Children in the Workplace
- 2019.02 Encrypted USB Flash Drive Assignment
- 2020.01 Quality Assurance for the Texas HIV Medication Program’s Eligibility Processes
- 410.001 Hepatitis B Vaccination for Adolescents
- 410.003 Accelerated HIV Intervention Program, Addressing the Potential for Recalcitrant Transmission of HIV in Texas
- Repealed Policies and Procedures
- 2023.004 340B Patient Eligibility
- 2023.005 Covered Entity Eligibility and Central Distribution Model Participation
- 2023.006 Prevention of Diversion of 340B Medication
- 2023.008 Covered Entity Ordering and Inventory Tracking
- 2023.009 340B Material Breach Policy
- 2023.010 340B Database Registration, Recertification, and Review
- 2023.011 Penicillin G Benzathine (Bicillin) Treatment
- 2023.013 340B Authorizing Official Back-up
- 2023.007 Prevention of Duplicate Discounts
- 2023.16 340B Roles, Responsibilities, Training and Education
- HIV/STD Security Policies and Procedures
- Laws, Rules, and Authorization
-
- POPS Chapter 22 - Pre-Exposure Prophylaxis (PrEP) and Non-occupational Post-Exposure Prophylaxis (nPEP)
- POPS Chapter 13 - Administrative Agency Core Competencies
- POPS Appendix F - CDC Surveillance Case Definitions
- POPS Chapter 1 - Focused HIV/STI/HCV Testing, Counseling and Linkage to HIV Medical Care
- POPS Chapter 2 - Quality Assurance for Focused HIV Testing, Counseling, and Linkage to Care for HIV Prevention
- POPS Chapter 7 - HCV Testing
- POPS Chapter 8 - HIV/STI Surveillance
- POPS Chapter 9 - Disease Intervention Specialist Performance Standards
- POPS Chapter 10 - First-Line Supervisors Performance Standards
- POPS Chapter 11 - Regional and Local Health Department HIV/STD Program Manager Performance Standards
- POPS Chapter 12 - STI Clinical Standards
- POPS Chapter 16 - Routine HIV Screening in Healthcare Settings
- POPS Chapter 19 - Individual and Group HIV Prevention Interventions
- POPS Chapter 15 - Client Referral Standards
- POPS Chapter 17 - Health Insurance Program Standards
- POPS Chapter 18 - Pick-Up And Delivery Of Prescription And Over-The-Counter Medications Standards
- POPS Chapter 20 - Direct Client Services Volunteer Programs Standards
- POPS Appendix E - STD-MIS System Maintenance
- POPS Chapter 3 - HIV/STI Partner Services and Seropositive Notification
- POPS Chapter 4 - HIV Testing in STI Clinics
- POPS Chapter 14 - Client File Organization, Content and Security Standards
- POPS Chapter 24 - Structural Interventions for HIV Prevention
- POPS Chapter 23 - Congenital Syphilis
- POPS Chapter 25 - Tangible Reinforcements for HIV Prevention
-
- 2016.01 HIV/STD Section Confidential Information Security
- 2021.01 Appeals Requests Related to the Texas HIV Medication Program
- 020.050 Public Complaints Related to the Delivery of Section Programs
- 020.070 Placement of Educational Articles in Professional Publications
- 319.001 Data Management and Security External Quality Assurance Plan
- 320.001 Quality Assurance of Confidentiality for Internal Staff
- 900.002 Completing the Contractor Risk Assessment Tool
- 2020.01 Quality Assurance for the Texas HIV Medication Program’s Eligibility Processes
-
-
- Records Retention